MedTrace Logo

The Effects of Transcutaneous Electrical Nerve Stimulation in Patients With Total Knee Replacement

NCT05115565 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2021-11-10

No results posted yet for this study

Summary

Total Knee Replacement (TDP) is considered the best treatment option available when conservative methods such as anti-inflammatory or physical therapy fail. However, TDP surgeries are also a serious trauma that causes severe pain in patients. Uncontrollable pain exacerbates the stress response and causes morbidity and mortality by causing negative changes in the neuroendocrine, respiratory, cardiovascular, gastrointestinal, renal and immune systems. Therefore, the relief of pain has very important effects on the patient's recovery process, functional status and quality of life. Transcutaneous Electrical Nerve Stimulation (TENS) is one of the non-pharmacological methods for pain relief in TDP surgeries. This study was planned as a randomized controlled trial to examine the effects of TENS after TDP on acute pain, functionality and quality of life.

Conditions

  • Total Knee Replacement
  • Transcutaneous Electrical Nerve Stimulation
  • Total Knee Replacement Surgery

Interventions

DEVICE

TENS (Transcutaneous Electrical Nerve Stimulation) Application

Conventional (traditional) TENS will be applied to the patients. The frequency will be 100 Hz, the pulse width (time) will be 150 μs, the current intensity (amplitude) will be 30 mA. In addition to routine care and treatment, TENS will be applied to intervention group patients.

Sponsors & Collaborators

  • Bozok University

    lead OTHER

Principal Investigators

  • Nilgün Özbaş, Assist. Prof · Bozok University

  • Emre Ersoy, Assist. Prof · Bozok University

  • Hacı Ali Olçar, Doctor · Bozok University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-15
Primary Completion
2022-08-30
Completion
2022-11-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05115565 on ClinicalTrials.gov